India could see more than 62.4 million cases of tuberculosis in the two decades to 2040, with scaling-up of existing treatment regimens potentially generating at least US$28 billion in GDP gains
#####
In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine : http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004491
Article Title: Estimating the health and macroeconomic burdens of tuberculosis in India, 2021-2040: A fully-integrated modelling study
Author Countries : United Kingdom, Denmark
Funding: This work was funded by Johnson and Johnson, New Brunswick, NJ, USA, agreement number 2110-5191. All authors received this award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
PLOS Medicine
Computational simulation/modeling
Not applicable
Competing interests: The authors have declared that no competing interests exist.